Skip to main content
Article
Upregulation of calpastatin in regenerating and developing rat liver: Role in resistance against hepatotoxicity
Hepatology
  • Pallavi B. Limaye
  • Vishakha Bhave, Philadelphia College of Osteopathic Medicine
  • Prajakta S. Palkar
  • Udayan M. Apte
  • Sharmilee P. Sawant
  • Songtao Yu
  • John R. Latendresse
  • Janardan K. Reddy
  • Harihara M. Mehendale
Document Type
Article
Publication Date
1-1-2006
Abstract
Acute liver failure induced by hepatotoxic drugs results from rapid progression of injury. Substantial research has shown that timely liver regeneration can prevent progression of injury leading to a favorable prognosis. However, the mechanism by which compensatory regeneration prevents progression of injury is not known. We have recently reported that calpain released from necrotic hepatocytes mediates progression of liver injury even after the hepatotoxic drug is cleared from the body. By examining expression of calpastatin (CAST), an endogenous inhibitor of calpain in three liver cell division models known to be resistant to hepatotoxicity, we tested the hypothesis that increased CAST in the dividing hepatocytes affords resistance against progression of injury. Liver regeneration that follows CCL 4-induced liver injury, 70% partial hepatectomy, and postnatal liver development were used. In all three models, CAST was upregulated in the dividing/newly divided hepatocytes and declined to normal levels with the cessation of cell proliferation. To test whether CAST overexpression confers resistance against hepatotoxicity, CAST was overexpressed in the livers of normal SW mice using adenovirus before challenging them with acetaminophen (APAP) overdose. These mice exhibited markedly attenuated progression of liver injury and 57% survival. Whereas APAP-bioactivating enzymes and covalent binding of the APAP-derived reactive metabolites remained unaffected, degradation of calpain specific target substrates such as fodrin was significantly reduced in these mice. In conclusion, CAST overexpression could be used as a therapeutic strategy to prevent progression of liver injury where liver regeneration is severely hampered. Copyright © 2006 by the American Association for the Study of Liver Diseases.
Comments

This article was published in Hepatology, Volume 44, Issue 2, Pages 379-388.

The published version is available at http://dx.doi.org/10.1002/hep.21250.

Copyright © 2006 Scopus.

Citation Information
Pallavi B. Limaye, Vishakha Bhave, Prajakta S. Palkar, Udayan M. Apte, et al.. "Upregulation of calpastatin in regenerating and developing rat liver: Role in resistance against hepatotoxicity" Hepatology Vol. 44 Iss. 2 (2006) p. 379 - 388
Available at: http://works.bepress.com/vishakha_bhave/5/